Warfarin dose requirement during induction correlates with CYP2C9 genetic polymorphism.

被引：0
|
作者：
Muszkat, M [1 ]
Elami, A [1 ]
Krasilnikov, I [1 ]
Caraco, Y [1 ]
机构：
[1] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2002年 / 71卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P37 / P37
页数：1
相关论文
共 50 条
  • [41] Warfarin dose requirement for patients with both VKORCI 3673A/A and CYP2C9*3/*3 genotypes
    Fukuda, Tsuyoshi
    Tanabe, Tomoko
    Ohno, Masako
    Tougou, Katsuhiko
    Fujio, Yasushi
    Azuma, Junichi
    Yamamoto, Isamu
    Takeda, Akira
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (05) : 553 - 554
  • [42] Impact of CYP2C9 genetic polymorphism on warfarin sensitivity among acutely ill patients.
    Muszkat, M
    Krasilnikov, I
    Caraco, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P57 - P57
  • [43] Genetic analysis of CYP2C9 polymorphism in a Japanese population
    Nasu, K
    Kubota, T
    Ishizaki, T
    PHARMACOGENETICS, 1997, 7 (05): : 405 - 409
  • [44] Genetic polymorphism of cynomolgus and rhesus macaque CYP2C9
    Uno, Yasuhiro
    Matsushita, Akinori
    Murayama, Norie
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (01) : 130 - 132
  • [45] Genetic polymorphism of CYP2C9 in a Vietnamese population.
    Kim, K
    Sunwoo, Y
    Ryu, J
    Lee, S
    Yoon, Y
    Cha, I
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P68 - P68
  • [46] Genetic polymorphism of CYP2C9 in a Vietnamese Kinh population
    Lee, SS
    Kim, KM
    Thi-Le, H
    Yea, SS
    Cha, IJ
    Shin, DG
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 208 - 210
  • [47] THE INFLUENCE OF CYP2C9 POLYMORPHISM ON ANTICOAGULATION WITH WARFARIN IN PATIENTS WITH CEREBROVASCULAR DISEASE
    Atasoy, E. B.
    Celebi, A.
    Hakyemez, A.
    Kaymaz, C.
    Kurtuncu, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 93 - 93
  • [48] Association of Cyp2c9 gene polymorphism with bleeding as a complication of warfarin therapy
    Samardzija, Marina
    Topic, Elizabeta
    Stefanovic, Mario
    Zibar, Lada
    Samardzija, Goran
    Balen, Sanja
    Vcev, Aleksandar
    Domanovic, Dragoslav
    Mirat, Jure
    Barbic, Jerko
    COLLEGIUM ANTROPOLOGICUM, 2008, 32 (02) : 557 - 564
  • [49] Warfarin resistance with poor CYP2C9 activity and CYP2C9*1*2 genotype
    Dericioglu, N
    Babaoglu, MO
    Saygi, S
    Bozkurt, A
    Yasar, U
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (05) : 899 - 899
  • [50] The Relationship Between Warfarin Resistance and CYP2C9*2 and CYP2C9*3 Variations
    Kirac, Deniz
    Yaman, Aysun Erdem
    Doran, Tansu
    Altunok, Elif Cigdem
    MEDICAL JOURNAL OF BAKIRKOY, 2021, 17 (03) : 209 - 213
12345